These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25399278)

  • 1. Revascularization in stable coronary artery disease.
    Sherwood MW; Peterson ED
    JAMA; 2014 Nov; 312(19):2028-9. PubMed ID: 25399278
    [No Abstract]   [Full Text] [Related]  

  • 2. Coronary artery bypass grafting vs percutaneous coronary intervention in multivessel disease.
    Rodriguez AE; Fernandez-Pereira C; Mieres J
    JAMA Intern Med; 2014 Jun; 174(6):1007. PubMed ID: 24887763
    [No Abstract]   [Full Text] [Related]  

  • 3. Coronary artery bypass grafting vs percutaneous coronary intervention in multivessel disease.
    Takagi H; Umemoto T;
    JAMA Intern Med; 2014 Jun; 174(6):1006-7. PubMed ID: 24887761
    [No Abstract]   [Full Text] [Related]  

  • 4. Coronary artery bypass grafting vs percutaneous coronary intervention in multivessel disease--reply.
    Sipahi I
    JAMA Intern Med; 2014 Jun; 174(6):1007-8. PubMed ID: 24887764
    [No Abstract]   [Full Text] [Related]  

  • 5. Evolving treatment options in coronary artery disease.
    Katz MH
    JAMA Intern Med; 2014 Feb; 174(2):231. PubMed ID: 24296643
    [No Abstract]   [Full Text] [Related]  

  • 6. ACP Journal Club. Review: CABG reduces long-term mortality and morbidity more than PCI in multivessel coronary disease.
    Harskamp RE; Newby LK
    Ann Intern Med; 2014 Apr; 160(8):JC9. PubMed ID: 24733226
    [No Abstract]   [Full Text] [Related]  

  • 7. Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era.
    Sipahi I; Akay MH; Dagdelen S; Blitz A; Alhan C
    JAMA Intern Med; 2014 Feb; 174(2):223-30. PubMed ID: 24296767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The FREEDOM trial: a definitive answer to coronary artery bypass grafting or stents in patients with diabetes and multivessel coronary artery disease.
    Taggart DP
    Eur J Cardiothorac Surg; 2013 Dec; 44(6):978-9. PubMed ID: 24047712
    [No Abstract]   [Full Text] [Related]  

  • 9. Percutaneous Coronary Intervention of Left Main Disease: Pre- and Post-EXCEL (Evaluation of XIENCE Everolimus Eluting Stent Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) and NOBLE (Nordic-Baltic-British Left Main Revascularization Study) Era.
    Park DW; Park SJ
    Circ Cardiovasc Interv; 2017 Jun; 10(6):. PubMed ID: 28607000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary artery bypass graft surgery versus percutaneous coronary intervention with drug-eluting stents for left main coronary artery disease: A meta-analysis of randomized trials.
    Putzu A; Gallo M; Martino EA; Ferrari E; Pedrazzini G; Moccetti T; Cassina T
    Int J Cardiol; 2017 Aug; 241():142-148. PubMed ID: 28438354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients.
    Palmerini T; Serruys P; Kappetein AP; Genereux P; Riva DD; Reggiani LB; Christiansen EH; Holm NR; Thuesen L; Makikallio T; Morice MC; Ahn JM; Park SJ; Thiele H; Boudriot E; Sabatino M; Romanello M; Biondi-Zoccai G; Cavalcante R; Sabik JF; Stone GW
    Am Heart J; 2017 Aug; 190():54-63. PubMed ID: 28760214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CABG again outshines stenting for some patients with coronary artery blockage.
    Mitka M
    JAMA; 2013 Jan; 309(1):17-8. PubMed ID: 23280199
    [No Abstract]   [Full Text] [Related]  

  • 13. Meta-Analysis of Randomized Controlled Trials of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Left Main Coronary Artery Disease.
    Garg A; Rao SV; Agrawal S; Theodoropoulos K; Mennuni M; Sharma A; Garg L; Ferrante G; Meelu OA; Sargsyan D; Reimers B; Cohen M; Kostis JB; Stefanini GG
    Am J Cardiol; 2017 Jun; 119(12):1942-1948. PubMed ID: 28433215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choosing between percutaneous coronary intervention and coronary artery bypass grafting for patients with multivessel disease: what can we learn from the Arterial Revascularization Therapy Study (ARTS)?
    Berger PB; Sketch MH; Califf RM
    Circulation; 2004 Mar; 109(9):1079-81. PubMed ID: 15007018
    [No Abstract]   [Full Text] [Related]  

  • 15. The FREEDOM trial: in appropriate patients with diabetes and multivessel coronary artery disease, CABG beats PCI.
    Aggarwal B; Goel SS; Sabik JF; Shishehbor MH
    Cleve Clin J Med; 2013 Aug; 80(8):515-23. PubMed ID: 23908108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials.
    Mercado N; Wijns W; Serruys PW; Sigwart U; Flather MD; Stables RH; O'Neill WW; Rodriguez A; Lemos PA; Hueb WA; Gersh BJ; Booth J; Boersma E
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):512-9. PubMed ID: 16077421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Meta-analysis of long-term outcomes of percutaneous coronary intervention or coronary artery bypass graft surgery in coronary artery disease patients with multi-vessel and/or left main stem disease].
    Sun T; Wan Y; Liu Z; Zhang S; Guan F; Yao R; Zhang L; Li L; Zhang J; Kan Q
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Aug; 42(8):693-8. PubMed ID: 25388345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review of cost-effectiveness of percutaneous coronary intervention vs. surgery for the treatment of multivessel coronary artery disease in the drug-eluting stent era.
    Ariyaratne TV; Yap CH; Ademi Z; Rosenfeldt F; Duffy SJ; Billah B; Reid CM
    Eur Heart J Qual Care Clin Outcomes; 2016 Oct; 2(4):261-270. PubMed ID: 29474722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
    Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW;
    Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary artery bypass grafting is superior to first-generation drug-eluting stents for unprotected left main coronary artery disease: an updated meta-analysis of 4 randomized, controlled trials.
    Benedetto U; Ng C; Smith R; Raja SG;
    J Thorac Cardiovasc Surg; 2014 Nov; 148(5):2430-2. PubMed ID: 25224547
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.